 |
|
Association of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
To the Editor: The recent article by Dr Terry and colleagues1 provides important data on the chemopreventive effects of aspirin and breast cancer risk. It is likely that the preventive effect of nonsteroidal anti-inflammatory drugs (NSAIDs) is actually stronger than reported in this article. The analysis derived from the Long Island Breast Cancer Study Project was based only on reported use of aspirin, ibuprofen, or acetaminophen, so that any women who used other NSAIDs (including naproxen, etodolac, ketoprofen, and sulindac, which are available by prescription) would have been included in the nonuser category. Given that these medications are often used for arthritis or chronic pain, it is likely that a substantial number of the nonusers were actually regular users of prescription NSAIDs. This misclassification of users and nonusers would attenuate any true inverse association between NSAIDs and breast cancer.
In a recent population-based case-control study,2 we found stronger inverse associations . . . [Full Text of this Article]
Patricia G. Moorman, PhD
patricia.moorman@duke.edu
Department of Community and Family Medicine
Duke University Medical Center
Durham, NC
RELATED ARTICLES
Association of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk
Steven Woloshin and Lisa M. Schwartz
JAMA. 2004;292(12):1426-1427.
EXTRACT
| FULL TEXT
Association of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk—Reply
Mary Beth Terry, Marilie Gammon, and Alfred I. Neugut
JAMA. 2004;292(12):1427.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
IL6, Aspirin, Nonsteroidal Anti-inflammatory Drugs, and Breast Cancer Risk in Women Living in the Southwestern United States
Slattery et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:747-755.
ABSTRACT
| FULL TEXT
|
